Initial Treatment for Acute Gout
The first-line treatment options for acute gout flare include oral colchicine, NSAIDs, or oral glucocorticoids, with the choice based on patient-specific factors and comorbidities. 1
First-Line Treatment Options
Colchicine
- Recommended dosing regimen: 1.2 mg (two tablets) at the first sign of flare followed by 0.6 mg (one tablet) one hour later 2
- Maximum recommended dose for treatment of gout flares is 1.8 mg over a one-hour period 2
- Most effective when started within 24 hours of symptom onset 3, 1
- Common side effects include gastrointestinal symptoms (diarrhea, nausea, vomiting)
NSAIDs
- Full dosing at FDA-approved anti-inflammatory/analgesic doses 3
- Options include:
- Naproxen 500 mg twice daily
- Indomethacin 50 mg three times daily
- Ibuprofen 800 mg three times daily 1
- The most important determinant of therapeutic success is how soon NSAID therapy is initiated 4
- Caution in patients with renal impairment, peptic ulcer disease, uncontrolled hypertension, or heart failure 5
Oral Glucocorticoids
- Prednisone or prednisolone 30-35 mg daily for 3-5 days 1
- Alternative regimen: oral methylprednisolone dose pack 3
- Particularly useful when NSAIDs are contraindicated
Treatment Selection Algorithm
For mild/moderate pain (≤6/10) affecting 1-3 small joints or 1-2 large joints:
- Monotherapy with colchicine, NSAIDs, or oral glucocorticoids 3
For severe pain (≥7/10) or polyarticular attacks:
For patients who cannot take oral medications (NPO):
Special Considerations
Intra-articular Corticosteroids
- Highly effective for monoarticular gout, especially in patients with large joints 1
- Provides immediate reduction of painful intra-articular hypertension and pain relief within 48 hours 1
Elderly Patients
- Use NSAIDs with caution; prefer those with short plasma half-life (diclofenac, ketoprofen) 5
- Colchicine is often poorly tolerated in the elderly 5
- Corticosteroids (intra-articular or systemic) are increasingly used for acute gout flares in elderly patients with conditions that contraindicate NSAID therapy 5
Inadequate Response to Initial Therapy
If there is inadequate response to initial therapy (defined as <20% improvement in pain within 24 hours or <50% improvement after ≥24 hours):
- Consider alternative diagnoses 3
- Switch to another monotherapy or add a second recommended agent 3
- For severe refractory attacks, IL-1 inhibitors may be considered (anakinra or canakinumab) 3, 6
Important Clinical Pearls
- Treatment should be initiated within 24 hours of symptom onset for best results 3, 1
- Continue established urate-lowering therapy without interruption during an acute attack 3, 1
- Apply topical ice for additional relief 1
- Educate patients to initiate treatment upon signs and symptoms of an acute attack without needing to consult their healthcare provider for each episode 3
Common Pitfalls to Avoid
- Delaying treatment of acute flares beyond 24 hours of symptom onset 1
- Interrupting urate-lowering therapy during acute attacks 1
- Using high-dose colchicine regimens, which have significantly worse safety profiles than low-dose regimens 1
- Overlooking renal function when prescribing NSAIDs or colchicine 1
The evidence consistently supports that early intervention with any of these first-line agents leads to better outcomes, with the choice among them primarily guided by patient comorbidities and contraindications rather than significant differences in efficacy 7, 6.